News 07 Oct 2020 Lonza to start manufacturing Moderna’s Covid-19 vaccine this December Lonza's new building dedicated to the manufacturing of Moderna's Covid-19 vaccine will be operational starting December 2020. 300 million doses w...
News 27 Mayo 2020 Celonic agrees cooperation to combat coronavirus The Basel-based biopharmaceutical company Celonic Group has agreed a partnership with Airway Therapeutics from the USA. Together, the two compani...
Success stories 25 Mayo 2023 CSL Behring: “The deciding factors were time to market and the proven track record of the Bern site.” CSL Behring For over a century, CSL Behring (CSLB) has kept its founding promise to help patients suffering from rare and serious diseases. It specializes in...
News 06 Dic 2021 Roche tests able to detect Omicron The Roche subsidiary TIB Molbiol has developed new coronavirus testing kits that can also detect the new Omicron variant of the disease. These te...
News 07 Sep 2020 Roche testing for coronavirus and flu simultaneously The U.S. Food and Drug Administration has given the Basel-based life sciences company Roche authorization to use a test that simultaneously tests...
News 11 Ago 2020 Moderna driving forward production of vaccine from Basel The Swiss government has just signed a supply contract with Moderna for 4.5 million doses of a coronavirus vaccine. The US company is now opening...
News 27 Ene 2021 Institute develops double antibody against COVID-19 Researchers at the Institute for Research in Biomedicine have managed to combine two antibodies against COVID-19 into a single entity. This doubl...
News 30 Mar 2020 Hand sanitizer: a Swiss invention that has been saving lives for decades The most sought after product in the midst of the COVID-19 pandemic is a Swiss invention. The hydro-alcoholic gel was formulated in the 1970s by ...
News 10 Nov 2020 Memo Therapeutics raises 14 million Swiss francs The biotechnology company Memo Therapeutics has raised a total of 14 million Swiss francs as part of a Series B financing round. This should now ...
News 21 Ago 2020 Researchers develop novel approach against the coronavirus The Swiss National Science Foundation is funding a novel approach for a coronavirus vaccine. This approach developed by virologist Cornel Fraefel...
Actualités 30 Mar 2020 Le gel hydro-alcoolique, une invention suisse qui sauve des vies depuis des décennies Parmi les produits les plus convoités en pleine pandémie de coronavirus, le gel hydro-alcoolique est une invention suisse. Il a été formulé dans ...
Aktuell 06 Dic 2021 Roche-Tests können Omikron erkennen Die Roche-Tochter TIB Molbiol hat neue Corona-Tests entwickelt, die auch die neue Omikron-Variante erkennen können. Diese Tests sollen der Forsch...
Aktuell 20 Ene 2021 Swiss PharmaCan testet Anti-COVID-Medikament erfolgreich Swiss PharmaCan und die australische MGC Pharma haben die klinischen Phase II-Tests für ihren COVID-19-Therapiekandidaten ArtemiC erfolgreich abg...
Aktuell 07 Sep 2020 Roche testet gleichzeitig auf Corona und Grippe Die amerikanische Zulassungsbehörde erlaubt dem Basler Life Sciences-Konzern Roche, einen Test einzusetzen, mit dem gleichzeitig eine Corona- und...
Aktuell 11 Ago 2020 Moderna treibt Produktion von Impfstoff aus Basel voran Die Schweizer Regierung hat soeben einen Liefervertrag über 4,5 Millionen Dosen eines Impfstoffs gegen das Coronavirus mit Moderna vereinbart. Nu...